| US 7,538,110 B2 | ||
| Opioid antagonists | ||
| Roland E. Dolle, King of Prussia, Pa. (US); Bertrand Le Bourdonnec, East Fallowfield, Pa. (US); and Allan James Goodman, Media, Pa. (US) | ||
| Assigned to Adolor Corporation, Exton, Pa. (US) | ||
| Filed on Oct. 25, 2006, as Appl. No. 11/552,827. | ||
| Claims priority of provisional application 60/730609, filed on Oct. 27, 2005. | ||
| Prior Publication US 2007/0105863 A1, May 10, 2007 | ||
| Int. Cl. A01N 43/60 (2006.01); A61K 31/495 (2006.01); C07D 241/36 (2006.01) | ||
| U.S. Cl. 514—249 [544/349] | 90 Claims |
1. A compound of formula I:
![]() wherein:
R1 is —OH, —ORa, —CH2OH, —C(═O)OR6, —C(═O)NR6R7, or —NR6R7;
R2 and R3 are each independently alkyl or alkenyl;
R4 is H, alkyl, cycloalkyl, cycloalkylalkyl, aryl, heteroaryl, aralkyl, alkylaralkyl, or heteroarylalkyl;
R5 is H, alkyl, cycloalkyl, cycloalkylalkyl, aryl, heteroaryl, aralkyl, alkylaralkyl, heteroarylalkyl, —C(═O)OR8a, —S(═O)2R8a, —C(═O)R8b, or —C(═O)NR8bR8c;
R6 is H, alkyl, cycloalkyl, alkylcycloalkyl, or aralkyl;
R7 is H, alkyl, aralkyl, or aryl;
R8a is alkyl, cycloalkyl, cycloalkylalkyl, heteroaryl, heteroarylalkyl, aralkyl, or aryl;
R8b and R8c are each independently H, alkyl, cycloalkyl, cycloalkylalkyl, heteroaryl, heteroarylalkyl, aralkyl, or aryl; or R8b and R8c taken together with the nitrogen atom to which they are connected form a 4- to 8-membered heterocycloalkyl ring;
Ra is a hydroxyl protecting group; and
m and n are each 1;
or a pharmaceutically acceptable salt thereof.
|